Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive information.
This move came to light following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman later stated that the US was requesting health data for research and commercial gain but was not willing to share the benefits from future treatments.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more talks to secure a deal acceptable to both sides so the nation's vital HIV programme can proceed.
Wider Background
This rejection follows a comparable case in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government deals to enhance transparency and accountability.
Based on reports, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery with no assurance that the end products would be accessible to our people should a future disease outbreak arise."
National Interest and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one health agreements were upending structures previously set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This system is intended to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a manner that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks must proceed since a large portion of the nation's HIV programmes were funded by external financing.
"Where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
This impasse underscores the ongoing challenges between accepting vital foreign assistance and safeguarding a country's data in an ever more interconnected world.